Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$485,271
-$112,068 QoQ
Shares Held
3,841
-10.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,383
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. GILD ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
|
4,700 | $736,584 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $485,271 | 3,841 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $597,339 | 4,286 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $572,213 | 4,662 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $508,047 | 4,577 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $792,609 | 7,149 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $847,882 | 7,567 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,398,574 | 15,141 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $8,466,582 | 100,985 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $7,912,928 | 115,332 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $10,202,846 | 139,288 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $9,620,423 | 118,756 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,828,530 | 131,152 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $10,125,225 | 131,377 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $10,673,260 | 128,640 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $10,238,385 | 119,259 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $9,264,727 | 150,182 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $8,886,547 | 143,772 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $7,939,131 | 133,543 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $8,755,386 | 120,581 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $6,811,143 | 97,511 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $6,384,768 | 92,721 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $5,956,753 | 92,167 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $5,225,863 | 89,699 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $6,117,360 | 96,809 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $7,383,470 | 95,964 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $7,130,683 | 95,381 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||